Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00101335 · ClinicalTrials.gov registry record · Phase 2
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
A Phase 2 study, sponsored by Fox Chase Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00101335 is a Phase 2 study that has completed, run by Fox Chase Cancer Center.
The verdict
NCT00101335, a Phase 2 study, has completed, sponsored by Fox Chase Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of celecoxib may prevent or treat head and neck cancer. PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works compared to placebo in preventing head and neck cancer in patients with oral leukoplakia.
Interventions
- DRUG celecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-11 |
| Est. Completion | 2005-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00101335
The ClinicalTrials.gov registry entry for NCT00101335 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which celecoxib is the first listed.
NCT00101335 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00101335 about?
NCT00101335 is a clinical study titled "Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia". RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of celecoxib may prevent or treat head and neck cancer. PURPOSE: This randomized phase II trial is studying celecoxib to see how well it works compared to placebo in preventing head ...
What is the current status of trial NCT00101335?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-11. Estimated completion is 2005-01.
What interventions are being tested in trial NCT00101335?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00101335?
This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.